Kerusso Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.34M Buy
85,657
+7,859
+10% +$497K 1.75% 24
2026
Q2
$4.48M Buy
77,798
+14,756
+23% +$847K 1.63% 33
2026
Q1
$3.82M Sell
63,042
-4,485
-7% -$261K 1.91% 24
2025
Q4
$3.64M Buy
67,527
+12,988
+24% +$625K 1.68% 34
2025
Q3
$2.46M Buy
54,539
+36,742
+206% +$1.72M 1.51% 37
2025
Q2
$824K Sell
17,797
-30,656
-63% -$1.5M 0.51% 57
2025
Q1
$2.96M Buy
48,453
+1,238
+3% +$72.2K 1.88% 28
2024
Q4
$2.67M Buy
47,215
+104
+0.2% +$5.81K 1.71% 29
2024
Q3
$2.44M Buy
47,111
+2,863
+6% +$134K 1.55% 33
2024
Q2
$1.84M Buy
+44,248
New +$1.98M 1.33% 43

Other funds holding BMY

Kerusso Capital Management's BMY Position: Q3 2026 in Review

Kerusso Capital Management increased its Bristol-Myers Squibb (BMY) stake by 10% in Q3 2026, buying an estimated $497K and bringing the position to 85,657 shares worth $5.34M. The position accounts for 1.75% of the portfolio, ranked #24.

Kerusso Capital Management first reported a position in BMY in Q2 2024 and has held it in 10 quarters since. 2,570 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Kerusso Capital Management held 85,657 shares of Bristol-Myers Squibb worth $5.34M as of Q3 2026.
  • Kerusso Capital Management bought 7,859 Bristol-Myers Squibb shares in Q3 2026, an estimated $497K.
  • Bristol-Myers Squibb made up 1.75% of Kerusso Capital Management's portfolio in Q3 2026, its #24 holding.
  • Kerusso Capital Management first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 10 quarters since.
  • 2,570 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Kerusso Capital Management's 13F filing for Q3 2026, filed 27 Oct 2026.